Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.09
Delayed Data
As of 10:09am ET
 +0.09 / +3.00%
Today’s Change
1.62
Today|||52-Week Range
5.79
+15.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues74.7K41.5K149.8K52.0K
 
 
 
 
 
Cost of Goods Sold57.9K50.7K41.4K45.2K
 
 
 
 
 
Depreciation And Amortization1.4K711.00710.00710.00
 
 
 
 
 
 
Operating ExpensesGross Income15.4K-9.9K107.7K6.1K
 
 
 
 
 
General Expenses4.0M3.3M3.9M3.1M
 
 
 
 
 
Research And Development2.4M1.7M1.5M2.0M
 
 
 
 
 
Total Operating Expenses4.1M3.3M3.9M3.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.0M-3.3M-3.8M-3.0M
 
 
 
 
 
Interest Expense On Debt84.5K58.3K54.1K78.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.1M-3.3M-3.8M-3.1M
 
 
 
 
 
Net Income-4.1M-3.3M-3.8M-3.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.0M44.0M45.4M46.9M
 
 
 
 
 
Shares To Calculate EPS Diluted43.0M46.0M45.4M46.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.08-$0.08-$0.07
 
 
 
 
 
EPS Diluted-$0.10-$0.08-$0.08-$0.07